Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Increased expression of HLA DR2 in acquired aplastic anemia and its impact on response to immunosuppressive therapy.

JPMA. The Journal of the Pakistan Medical Association - 1 May 2004

Usman M, Adil S N, Moatter T, Bilwani F, Arian S, Khurshid M

Abstract excerpt

OBJECTIVE: To study the frequency of HLA DR2 status of patients with aplastic anemia and their response to immunosuppressive therapy at a tertiary care hospital. METHODS: Thirty eight consecutive patients of acquired aplastic anemia were evaluated with respect to demographic features, severity of HLA DR2 status and response outcome to immunosuppressive therapy. RESULTS: The mean age of the patients was 24.6 years...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anemia, Aplastic
Share to Child

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Child, Preschool

Share to Cross-Sectional Studies

Share to Histocompatibility Testing

Share to HLA-DR2 Antigen

Share to Immunosuppressive Agents

Share to Polymerase Chain Reaction

Source

Identifiers

PMID: 15270183

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Increased expression of HLA DR2 in acquired aplastic anemia and its impact on response to immunosuppressive therapy.PMID 15270183Read ↗

HLA association is different in children and adults with severe acquired aplastic anemia.Semantic proximity Read ↗

Association of human leukocyte antigen class II alleles with response to immunosuppressive therapy in Korean aplastic anemia patients.Semantic proximity Read ↗

Associations between the HLA-A/B/DRB1 polymorphisms and aplastic anemia: evidence from 17 case-control studies.Semantic proximity Read ↗

Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome.Semantic proximity Read ↗

HLA-DR-negative AML (M1 and M2): FLT3 mutations (ITD and D835) and cell-surface antigen expression.Semantic proximity Read ↗

Association of human leukocyte antigen-DRB1 alleles with disease susceptibility and severity of aplastic anemia in Korean patients.Semantic proximity Read ↗

[Relationship between polymorphism of HLA-A, -B, -DRB1 alleles and susceptibility of children to acquired aplastic anemia].Semantic proximity Read ↗

Aplastic anemia is associated with HLA-DRB1*1501 in northern Han Chinese.Semantic proximity Read ↗

[Expression of HLA-DRB1*15 genotype in children with acquired aplastic anemia and its relation to effect of immunosuppressive therapy].Semantic proximity Read ↗

Interleukin-1 Receptor Antagonist Gene Polymorphisms in Egyptian Children and Adolescents With Primary Immune Thrombocytopenia: Association With Disease Susceptibility, Response to Therapy, and Outcome.Semantic proximity Read ↗

HLA-DR4-Ala74 beta is associated with risk and poor outcome of severe aplastic anemia.Semantic proximity Read ↗

Correlations between HLA-A, HLA-B and HLA-DRB1 allele polymorphisms and childhood susceptibility to acquired aplastic anemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.